These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32892202)

  • 1. Clinical Characteristics and Risk Factors for Mortality due to Bloodstream Infection of Unknown Origin in Hemodialysis Patients: A Single-Center, Retrospective Study.
    Shima H; Okamoto T; Tashiro M; Inoue T; Masaki C; Tanaka Y; Tada H; Takamatsu N; Wariishi S; Kawahara K; Okada K; Nishiuchi T; Minakuchi J
    Blood Purif; 2021; 50(2):238-245. PubMed ID: 32892202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of methicillin-resistant Staphylococcus aureus bloodstream infection: do we need rapid diagnostic tests?
    Delerue T; Cordel H; Delerue T; Figoni J; Dziri S; Billard-Pomares T; Bouchaud O; Carbonnelle E; Zahar JR
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1319-1326. PubMed ID: 30982159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study.
    Stewardson AJ; Allignol A; Beyersmann J; Graves N; Schumacher M; Meyer R; Tacconelli E; De Angelis G; Farina C; Pezzoli F; Bertrand X; Gbaguidi-Haore H; Edgeworth J; Tosas O; Martinez JA; Ayala-Blanco MP; Pan A; Zoncada A; Marwick CA; Nathwani D; Seifert H; Hos N; Hagel S; Pletz M; Harbarth S;
    Euro Surveill; 2016 Aug; 21(33):. PubMed ID: 27562950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USA300 methicillin-resistant Staphylococcus aureus emerging as a cause of bloodstream infections at military medical centers.
    Sherwood J; Park M; Robben P; Whitman T; Ellis MW
    Infect Control Hosp Epidemiol; 2013 Apr; 34(4):393-9. PubMed ID: 23466913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation and Validation of a Risk Score for Methicillin-Resistant Staphylococcus aureus Bloodstream Infection.
    Wu TG; Huang XM; Xiao XD
    Clin Lab; 2023 Sep; 69(9):. PubMed ID: 37702692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
    Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
    Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012.
    Simor AE; Pelude L; Golding G; Fernandes R; Bryce E; Frenette C; Gravel D; Katz K; McGeer A; Mulvey MR; Smith S; Weiss K;
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):390-7. PubMed ID: 26782274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York.
    Yasmin M; El Hage H; Obeid R; El Haddad H; Zaarour M; Khalil A
    Am J Infect Control; 2016 Jan; 44(1):41-6. PubMed ID: 26412481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-Susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable
    Jones D; Elshaboury RH; Munson E; Dilworth TJ
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038267
    [No Abstract]   [Full Text] [Related]  

  • 11. Nosocomial bloodstream infection in patients caused by Staphylococcus aureus: drug susceptibility, outcome, and risk factors for hospital mortality.
    Chen R; Yan ZQ; Feng D; Luo YP; Wang LL; Shen DX
    Chin Med J (Engl); 2012 Jan; 125(2):226-9. PubMed ID: 22340550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
    Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY
    J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss.
    Herzke CA; Chen LF; Anderson DJ; Choi Y; Sexton DJ; Kaye KS
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1057-61. PubMed ID: 19803766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus.
    Harbarth S; Rutschmann O; Sudre P; Pittet D
    Arch Intern Med; 1998 Jan; 158(2):182-9. PubMed ID: 9448557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant
    Wu X; Yu H; He LY; Wang CQ; Xu HM; Zhao RQ; Jing CM; Chen YH; Chen J; Deng JK; Shi J; Lin AW; Li L; Deng HL; Cai HJ; Chen YP; Wen ZW; Yang JH; Zhang T; Xiao FF; Cao Q; Huang WC; Hao JH; Zhang CH; Huang YY; Ji XF
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):628-634. PubMed ID: 32842382
    [No Abstract]   [Full Text] [Related]  

  • 16. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS).
    Gastmeier P; Sohr D; Geffers C; Behnke M; Daschner F; Rüden H
    Infection; 2005 Apr; 33(2):50-5. PubMed ID: 15827870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence and risk factors for methicillin-resistant Staphylococcus aureus colonization among outpatients undergoing hemodialysis treatment].
    Köseoğlu O; Sayın Kutlu S; Cevahir N
    Mikrobiyol Bul; 2012 Jan; 46(1):106-12. PubMed ID: 22399178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections.
    de Kraker ME; Wolkewitz M; Davey PG; Koller W; Berger J; Nagler J; Icket C; Kalenic S; Horvatic J; Seifert H; Kaasch AJ; Paniara O; Argyropoulou A; Bompola M; Smyth E; Skally M; Raglio A; Dumpis U; Kelmere AM; Borg M; Xuereb D; Ghita MC; Noble M; Kolman J; Grabljevec S; Turner D; Lansbury L; Grundmann H;
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1598-605. PubMed ID: 21220533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and short-term outcomes for methicillin-resistant
    Price AM; Sarween N; Gupta I; Baharani J
    Saudi J Kidney Dis Transpl; 2019; 30(6):1351-1363. PubMed ID: 31929282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done.
    Fitzgerald SF; O'Gorman J; Morris-Downes MM; Crowley RK; Donlon S; Bajwa R; Smyth EG; Fitzpatrick F; Conlon PJ; Humphreys H
    J Hosp Infect; 2011 Nov; 79(3):218-21. PubMed ID: 21856042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.